GILD ▲ +2.4% - Gilead Sciences, Inc. $GILD - TO ACQUIRE ORAL IL-23R INHIBITOR HCXT-2001 FOR $1.27B IN UPFRONT CASH 22-OCT-2026 04:06 PM ET